Implantable Cardioverter Defibrillator (ICD)

This channel includes news and new technology innovations for implantable cardioverter defibrillators (ICD) used to treat tachycardia arrhythmias and heart failure. This includes cardiac resynchronization therapy defibrillators (CRT-D).

Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD) | July 06, 2017

July 6, 2017 — Two predictive models may help cardiologists decide which patients would most benefit from an...

Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population
News | Atrial Fibrillation | July 03, 2017

July 3, 2017 — Medtronic recently announced that its Reactive ATP therapy slows the progression of...

Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab | June 22, 2017 | Dave Fornell

Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...

Videos | Leads Implantable Devices | May 25, 2017

Bruce Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, discusses...

Boston Scientific S-ICD system with the subcutaneous lead
News | Implantable Cardioverter Defibrillator (ICD) | May 17, 2017

May 12, 2017 – Results from the U.S. post-market approval study evaluating “real-world” patients implanted with the...

NewPace ISSD string subcutaneous ICD system

The NewPace string subcutaneous ICD system.

News | May 16, 2017

May 16, 2017 – A new study examines the effectiveness of the implantable subcutaneous string defibrillator (ISSD), a...

Boston Scientific's Resonate X4 CRT-D system
Technology | Cardiac Resynchronization Therapy Devices (CRT) | May 09, 2017

May 9, 2017 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific’s Resonate family of...

WiSE CRT System is a wireless cardiac resynchonization therapy device with no lead wires

The WiSE CRT System uses a tiny implant in the left ventricle to synchronize the heart, overcoming limitations of traditional Cardiac Resynchronization Therapy (CRT) in heart failure patients.

News | Heart Failure | May 12, 2017

May 12, 2017 – New study proves safety of novel, wireless pacing system, WiSE CRT (Wireless Stimulation...

The Unify ICD is one of the SJM devices in an FDA warning letter
Feature | Implantable Cardioverter Defibrillator (ICD) | April 14, 2017 | Dave Fornell

April 14, 2017 — The U.S. Food and Drug Administration (FDA) sent a warning letter to Abbott/St. Jude Medical (SJM)...

An electrophysiology EP ablation procedure to treat a heart arrhythmia
Feature | HRS | May 16, 2017

May 16, 2017 — Here is a list of the late-breaking clinical trials presented at the Heart Rhythm Society (HRS) 2017...

Biotronik Launches New ICD Lead With Helical Design in Europe
News | Leads Implantable Devices | April 12, 2017

April 12, 2017 — Biotronik announced the European launch of a new lead for...

Videos | EP Lab | April 10, 2017

A discussion with Heart Rhythm Society (HRS) President...

Overlay Init